Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
about
Metabolic aspects of adult patients with nonalcoholic fatty liver diseaseMetabolism Disrupting Chemicals and Metabolic DisordersNonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in MiceHedgehog signaling is a potent regulator of liver lipid metabolism and reveals a GLI-code associated with steatosis.Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations PatientsLoss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress.Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility.Non-alcoholic fatty liver disease-From the cardiologist perspective.The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target?Normal weight dyslipidemia: Is it all about the liver?Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis.Editorial: new insights into the relationship between the intestine and non-alcoholic fatty liver-is "fatty gut" involved in disease progression?Impaired branched-chain amino acid metabolism may underlie the nonalcoholic fatty liver disease-like pathology of neonatal testosterone-treated female rats.Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease.Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver.The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro.Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.Effect of PNPLA3 I148M polymorphism on histologically proven non-alcoholic fatty liver disease in liver transplant recipients.NAFLD risk alleles in PNPLA3, TM6SF2, GCKR, and LYPLAL1 show divergent metabolic effects.Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease.Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist.Human hepatic 3D spheroids as a model for steatosis and insulin resistance
P2860
Q28067490-84E0FE8C-83C0-4C8F-B5B4-8E466B97BCD1Q29248099-D432A670-AFC0-43D9-BD79-7F3C67C19B1DQ33855157-78A1BE5E-D3AD-4A6A-BC6A-7A4FF8517BF8Q36828380-A3C7AA39-55C8-4203-B3FF-0EDF8BD5FDA5Q36908863-5534B0DC-9839-4F79-8431-A917C3A3E216Q36996996-C71CD153-0439-4FC8-95A3-3A313A1E18B7Q37461675-D41B2A81-F4BC-4656-BDA4-2CA424A6A5DAQ37587055-3B3763B1-03B4-4F79-B3D9-954E542DBDE8Q37672952-DA202DFF-C1CF-4B77-BC5B-2302115C3B0EQ38660769-6B4F4AEA-C9FD-4527-917D-9627AE811D84Q38730392-41D7D9D0-F548-4DD4-87FD-051893D98F6CQ38790052-79BB6E8A-25DE-4A35-8F8D-9E4D68883A5CQ38859044-47164242-1828-4C92-A1F8-77E6C3F2536BQ39062036-8247B695-4543-4BCD-B420-9A99E1744A00Q40071098-08579C37-F80E-4AC3-A147-AA4E0F3B6811Q42335229-445DC0E6-BE2F-477F-A52E-CA3892C5C4D2Q42377175-EE232A3D-FBF2-4EF2-B031-CFC89D4F6830Q44339679-C9249AC4-94D9-477D-83A3-5FD937D9D62EQ47245103-67022B55-FFA7-4105-98FE-86BB1DC8F2A6Q47436758-1CB0BFDC-85DC-4816-A7DF-7DE71C61EFC8Q48196520-7305A5BE-1177-4482-9247-04C0054DCE70Q50044216-3B61F90C-CA35-4EC7-8569-C5A22EF0942DQ50526705-D2AA2384-02A9-4EBF-992E-36F3DDEB805AQ52323790-552E45AA-D387-4420-ABAE-68896BFC499FQ54948913-6BF78269-B650-41B1-869C-B7C624AC4E10Q55032630-30F08A79-C907-4978-B9C4-1FA923E8341EQ58700518-B0615A68-6861-4E45-9B5D-87D31815F3E0
P2860
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
@ast
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
@en
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
@nl
type
label
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
@ast
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
@en
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
@nl
prefLabel
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
@ast
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
@en
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
@nl
P2860
P921
P3181
P356
P1476
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
@en
P2093
Paola Dongiovanni
P2860
P304
P3181
P356
10.1155/2015/460190
P407
P5008
P577
2015-07-27T00:00:00Z